- A-Z Publications
- Southern African Journal of Anaesthesia and Analgesia
- Previous Issues
- Volume 8, Issue 3, 2002
Southern African Journal of Anaesthesia and Analgesia - Volume 8, Issue 3, 2002
Volumes & issues
Volume 8, Issue 3, 2002
Author Christina LundgrenSource: Southern African Journal of Anaesthesia and Analgesia 8 (2002)More Less
Extracted from text ... EDITORIAL Professor Christina Lundgren - Editor-in-chief It is now almost a year since we launched the new look SAJAA as the official journal of the South African Society of Anaesthesiologists. My sincere thanks to all those who have contributed to the Journal, and the members of the Editorial Board who have peer reviewed these contributions. Our publisher has recently set up a new SAJAA website, as the previous "shared" website has been such a success. SASA's communication Pipeline, has been resurrected, and will be distributed together with SAJAA. It has been decided by SASA Council that ..
Source: Southern African Journal of Anaesthesia and Analgesia 8, pp 4 –7 (2002)More Less
Objectives : To assess the effect of midazolam 0.02 mg / kg administered with etomidate on the incidence of myoclonus and the dose requirement for etomidate to induce general anaesthesia. <br>Design : Double blind randomised control trial. <br>Setting : Two urban teaching hospitals in Durban, Kwa Zulu Natal (KZN). <br>Patients : 60 patients older than 60 years of age undergoing intraocular surgery. <br>Outcome measures : Etomidate dose required for loss of verbal contact (dose V) and loss of eyelash reflex (dose E). Myoclonus assessed by means of a three-point scale (0-nil; 1-mild; 2-severe) 30 sec after the last dose of etomidate. Duration of recovery from cessation of anaesthesia to first response to verbal command. <br>Results : No significant difference in myoclonus or dose requirement for etomidate could be demonstrated. There was no difference in haemodynamic variation between the groups and recovery time was not prolonged. <br>Conclusion : Midazolam 0.02 mg / kg given with etomidate for induction of anaesthesia does not reduce myoclonus or dose requirement for etomidate. Further studies may be undertaken to assess the usefulness of larger doses of midazolam for co-induction or oral premedication with midazolam.
Author W. PearceSource: Southern African Journal of Anaesthesia and Analgesia 8, pp 8 –24 (2002)More Less
Extracted from text ... REVIEW ARTICLE W Pearce, MBBCh (Witwatersrand) MMed (Anaesth) (Pretoria) FCA (CMSA) Department of Anaesthesiology, Pretoria Academic Hospital and the , University of Pretoria Correspondence: Dr W Pearce Daether@icon.co.za The Cardiovascular Autonomic Nervous System and Anaesthesia Once awareness, our seat of deliberate action and movement, is temporarily extinguished by sleep or a loss of consciousness, we rely on a primordial, indispensable, and autonomous ("vegetative") system that continues to sustain and control our vital organ systems. This vegetative system is never allowed to rest. The Cambridge physiologist J N Langley referred to it as the autonomic ..
Author K.M. KuczkowskiSource: Southern African Journal of Anaesthesia and Analgesia 8, pp 26 –32 (2002)More Less
The illicit drug abuse in pregnancy has received significant attention over the past two decades. However, far too little attention has been given to the consequences of the use of social drugs such as ethanol and tobacco, which are by far the most commonly abused substances during pregnancy. While the deleterious effects of cocaine or amphetamines on the mother and the fetus are more pronounced and easier to detect, the addiction to ethanol and tobacco is usually subtle and more difficult to diagnose. As a result recreational use of alcohol and tobacco may continue undetected in pregnancy, significantly effecting pregnancy outcome and obstetric and anaesthetic management of these patients. This article reviews the consequences of ethanol and tobacco use in pregnancy and offers recommendation for anaesthetic management of these potentially complicated pregnancies.
Author M. RaffSource: Southern African Journal of Anaesthesia and Analgesia 8, pp 34 –38 (2002)More Less
Combination analgesics are frequently prescribed for the treatment of a multitude of conditions. Many of these preparations contain agents with no proven analgesic efficacy. We examined 3059 patients using a new combination agent containing only paracetamol, codeine, and ibuprofen. It appears that despite a wide variation in the administration of the tablet that good pain relief was obtained by the patients. Patient compliance and tolerance of the tablet was good. A small number of adverse events was noted and these were mostly related to the non-steroidal anti-inflammatory component of the tablet. None of the adverse events were considered serious. The tablet was prescribed for a wide range of conditions, most of which involved pain of an inflammatory nature. Most patients indicated that they would use this preparation again if needed.
Source: Southern African Journal of Anaesthesia and Analgesia 8 (2002)More Less
Extracted from text ... CPD QUESTIONNAIRE Southern African Journal of Anaesthesia & Analgesia - July 2002 40 Subscribe to the SAJAA and earn 15 CPD points per year CPD reference number A008/016/03/2002 Continuing Professional Development Point Questionnaire Accredited by the Wits CPD Office 1. The daily dose of paracetamol should not exceed 6 grams. (a) true (b) false 2. The WHO suggests that pain be treated following a "four rung ladder" model. (a) true (b) false 3. The recommended daily dose of codeine is 100 mg. (a) true (b) false 4. NSAID's and paracetamol act via the same enzyme system. (a) true (b) false ..